View:
As filed with the Securities and Exchange Commission on April 20, 1995 Registration No. 33-38347 ______________________________________________________________________ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________ POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________ ELI LILLY AND COMPANY (Exact name of registrant as specified in its charter) ____________ Indiana 35-0470950 (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) Lilly Corporate Center Indianapolis, Indiana 46285 317-276-2000 (Address, including zip code, and telephone number, including area code of registrant's principal executive offices) ____________ REBECCA O. GOSS, Esq. Vice President and General Counsel Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285 317-276-2000 (Name, address, including zip code, and telephone number, including area code of agent for services) ____________ Copies to: Steven P. Lund, Esq. Keith L. Kearney, Esq. Dewey Ballantine Davis Polk & Wardwell 1301 Avenue of the Americas 450 Lexington Avenue New York, New York 10019-6092 New York, New York 10017 ______________________________________________________________________ By filing this Post-Effective Amendment No. 1 to its Registration Statement with the Securities and Exchange Commission (the "Commission"), the Registrant is requesting the deregistration of $24,250,000 aggregate principal amount of Debt Securities. Registrant previously registered $500,000,000 aggregate principal amount of Debt Securities with the Commission. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Indianapolis, State of Indiana, on April 17, 1995. ELI LILLY AND COMPANY By /s/ Randall L. Tobias _________________________________________ (Randall L. Tobias, Chairman of the Board and Chief Executive Officer) Pursuant to the requirements of the Securities Act of 1933, this Amendment to the Registration Statement has been signed by the following persons in the capacities and on the date indicated. Signature Title Date /s/ Randall L. Tobias Chairman of the Board, April 17, 1995 ___________________________________ Chief Executive (Randall L. Tobias) Officer, and a Director (principal executive officer) /s/ James M. Cornelius Vice President, Finance, April 17, 1995 ___________________________________ Chief Financial (James M. Cornelius) Officer, and a Director (principal financial officer) /s/ Arnold C. Hanish Chief Accounting Officer April 17, 1995 ___________________________________ (principal accounting (Arnold C. Hanish) officer) /s/ Steven C. Beering, M.D. Director April 17, 1995 ___________________________________ (Steven C. Beering, M.D.) Director April 17, 1995 ___________________________________ (James W. Cozad) /s/ Alfred G. Gilman, M.D., Ph.D. Director April 17, 1995 ___________________________________ (Alfred G. Gilman, M.D., Ph.D.) Signature Title Date /s/ Karen N. Horn, Ph.D. Director April 17, 1995 ________________________________________ (Karen N. Horn, Ph.D.) /s/ J. Clayburn La Force, Jr., Ph.D. Director April 17, 1995 ________________________________________ (J. Clayburn La Force, Jr., Ph.D.) /s/ Kenneth L. Lay, Ph.D. Director April 17, 1995 ________________________________________ (Kenneth L. Lay, Ph.D.) /s/ Franklyn G. Prendergast, M.D., Ph.D. Director April 17, 1995 ________________________________________ (Franklyn G. Prendergast, M.D., Ph.D.) /s/ Kathi P. Seifert Director April 17, 1995 ________________________________________ (Kathi P. Seifert) /s/ Stephen A. Stitle Director April 17, 1995 ________________________________________ (Stephen A. Stitle) /s/ Sidney Taurel Director April 17, 1995 ________________________________________ (Sidney Taurel) /s/ August M. Watanabe, M.D. Director April 17, 1995 ________________________________________ (August M. Watanabe, M.D.) /s/ Alva O. Way Director April 17, 1995 ________________________________________ (Alva O. Way) /s/ Richard D. Wood Director April 17, 1995 ________________________________________ (Richard D. Wood) April 20, 1995 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Eli Lilly and Company Post-Effective Amendment No. 1 to Form S-3 Registration Statement (Registration No. 33-38347) ________________________________________ Dear Sirs: On behalf of Eli Lilly and Company (the "Company"), transmitted herewith by electronic transmission under the EDGAR system is Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 (Registration No. 33-38347) (the "Amendment"). By this Amendment, the Company is deregistering $24,250,000 aggregate principal amount of Debt Securities. Should you have any questions in connection with this filing, please call me collect at (212) 259-6746. Very truly yours, Joon S. Kim Enclosures